Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국
화요일, 9월 01

Inspire Medical Systems Inc

INSPNYSE
Trade with Public
Trade with Public
$62.99
1.552.52%
가까이에: Aug 31, 5:00 PM EST
$63.05
0.060.1%
시간외: 6:03 PM EST
개요뉴스실적 전망이벤트목표가재무심리지분 현황비교옵션주식 보고서

Inspire Medical Systems Analyst Price Targets

Wall Street analyst price targets and consensus rating for Inspire Medical Systems (INSP).

Price Target Range — 9 Quarters

Analyst Consensus — 15 Analysts

6Buy
8Hold
1Sell
Consensus RatingBuy# Analysts15Avg. Consensus PT$83Upside to Avg. PT+32.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 4, 2026JP MorganRobbie MarcusPT RaiseNeutral$54→$60
Aug 4, 2026MizuhoAnthony PetronePT RaiseOutperform$55→$65
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
JP Morgan Maintains Neutral on Inspire Medical Systems, Raises Price Target to $60

JP Morgan analyst Robbie Marcus maintains Inspire Medical Systems (NYSE:INSP) with a Neutral and raises the price target from $54 to $60.
Benzinga Newsdesk

PRO
Mizuho Maintains Outperform on Inspire Medical Systems, Raises Price Target to $65

Mizuho analyst Anthony Petrone maintains Inspire Medical Systems (NYSE:INSP) with a Outperform and raises the price target from $55 to $65.
Benzinga Newsdesk

PRO
Oppenheimer Upgrades Inspire Medical Systems to Outperform, Announces $85 Price Target

Oppenheimer analyst Suraj Kalia upgrades Inspire Medical Systems (NYSE:INSP) from Perform to Outperform and announces $85 price target.
Benzinga Newsdesk

PRO
Truist Securities Reiterates Hold on Inspire Medical Systems, Raises Price Target to $62

Truist Securities analyst Richard Newitter reiterates Inspire Medical Systems (NYSE:INSP) with a Hold and raises the price target from $54 to $62.
Benzinga Newsdesk

PRO
Evercore ISI Group Maintains In-Line on Inspire Medical Systems, Raises Price Target to $54

Evercore ISI Group analyst Daniel Markowitz maintains Inspire Medical Systems (NYSE:INSP) with a In-Line and raises the price target from $40 to $54.
Benzinga Newsdesk

Inspire Medical Systems Analysts Raise Their Forecasts Following Strong Q2 Results

INSPI beats expectations, raises FY26 guidance. Analysts raise price targets to $59 & $60. Stock jumps 14.6% in pre-market trading. #INSP
Avi Kapoor

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

시장 데이터 제공 Benzinga API

Benzinga

Benzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved